IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Chairman's Address to Shareholders and Presentation, page-45

  1. 17,528 Posts.
    lightbulb Created with Sketch. 422
    2 June news


    Due to the ongoing liquidation of Warambi Sarl a company of which Dr Jason Loveridge is a shareholder and beneficiary, the beneficial interests of the shareholding in Invex have been distributed to the respective beneficiaries. As a result, Warambi Sarl’s shareholding in Invex have been transferred to Warambi Ltd (a company which Dr Jason Loveridge is a shareholder and beneficiary), Dr Jason Loveridge and the balance of the shareholding has been transferred to other beneficiaries of which Dr Jason Loveridge does not have a ‘notifiable’ interest. The escrowed portion of these shares remain escrowed until 3 July 2021

    I don’t know who the “ other beneficiaries “ are or why this liquidation was needed?


    Maybe the other beneficiaries are sellers.?

    all just speculation
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.335M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $2.546K 35.86K

Buyers (Bids)

No. Vol. Price($)
1 14158 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 14.37pm 31/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.